List of Tables
    Table 1. Antibody and Recombinant Protein CDMO Market Opportunities & Trends in Global Market
    Table 2. Antibody and Recombinant Protein CDMO Market Drivers in Global Market
    Table 3. Antibody and Recombinant Protein CDMO Market Restraints in Global Market
    Table 4. Key Players of Antibody and Recombinant Protein CDMO in Global Market
    Table 5. Top Antibody and Recombinant Protein CDMO Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Antibody and Recombinant Protein CDMO Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Antibody and Recombinant Protein CDMO Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Antibody and Recombinant Protein CDMO Product Type
    Table 9. List of Global Tier 1 Antibody and Recombinant Protein CDMO Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Antibody and Recombinant Protein CDMO Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Antibody and Recombinant Protein CDMO Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Antibody and Recombinant Protein CDMO Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Antibody and Recombinant Protein CDMO Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Antibody and Recombinant Protein CDMO Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Antibody and Recombinant Protein CDMO Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Antibody and Recombinant Protein CDMO Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2023-2028
    Table 30. Batavia Biosciences Corporate Summary
    Table 31. Batavia Biosciences Antibody and Recombinant Protein CDMO Product Offerings
    Table 32. Batavia Biosciences Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 33. Grifols Corporate Summary
    Table 34. Grifols Antibody and Recombinant Protein CDMO Product Offerings
    Table 35. Grifols Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 36. Cerbios-Pharma SA Corporate Summary
    Table 37. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Product Offerings
    Table 38. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 39. HALIX Corporate Summary
    Table 40. HALIX Antibody and Recombinant Protein CDMO Product Offerings
    Table 41. HALIX Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 42. Biovian Oy Corporate Summary
    Table 43. Biovian Oy Antibody and Recombinant Protein CDMO Product Offerings
    Table 44. Biovian Oy Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 45. Catalent Corporate Summary
    Table 46. Catalent Antibody and Recombinant Protein CDMO Product Offerings
    Table 47. Catalent Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 48. Goodwin Biotechnology Corporate Summary
    Table 49. Goodwin Biotechnology Antibody and Recombinant Protein CDMO Product Offerings
    Table 50. Goodwin Biotechnology Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 51. Merck Corporate Summary
    Table 52. Merck Antibody and Recombinant Protein CDMO Product Offerings
    Table 53. Merck Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 54. Hangzhou Hs-biopharm Corporate Summary
    Table 55. Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Product Offerings
    Table 56. Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 57. Wuxibiologics Corporate Summary
    Table 58. Wuxibiologics Antibody and Recombinant Protein CDMO Product Offerings
    Table 59. Wuxibiologics Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 60. Bioinnobio Corporate Summary
    Table 61. Bioinnobio Antibody and Recombinant Protein CDMO Product Offerings
    Table 62. Bioinnobio Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 63. Thousand Oaks Biopharmaceuticals Corporate Summary
    Table 64. Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Product Offerings
    Table 65. Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 66. Cerbios-Pharma SA Corporate Summary
    Table 67. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Product Offerings
    Table 68. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 69. Eurogentec Corporate Summary
    Table 70. Eurogentec Antibody and Recombinant Protein CDMO Product Offerings
    Table 71. Eurogentec Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 72. HJB Corporate Summary
    Table 73. HJB Antibody and Recombinant Protein CDMO Product Offerings
    Table 74. HJB Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 75. Bibo Pharma Corporate Summary
    Table 76. Bibo Pharma Antibody and Recombinant Protein CDMO Product Offerings
    Table 77. Bibo Pharma Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 78. MabPlex International Corporate Summary
    Table 79. MabPlex International Antibody and Recombinant Protein CDMO Product Offerings
    Table 80. MabPlex International Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 81. Genscriptprobio Corporate Summary
    Table 82. Genscriptprobio Antibody and Recombinant Protein CDMO Product Offerings
    Table 83. Genscriptprobio Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 84. Vetter Corporate Summary
    Table 85. Vetter Antibody and Recombinant Protein CDMO Product Offerings
    Table 86. Vetter Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 87. Etinpro (Beijing) Co Corporate Summary
    Table 88. Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Product Offerings
    Table 89. Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 90. Boehringer Ingelheim BioXcellence Corporate Summary
    Table 91. Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Product Offerings
    Table 92. Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 93. Lonza Corporate Summary
    Table 94. Lonza Antibody and Recombinant Protein CDMO Product Offerings
    Table 95. Lonza Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 96. 3SBio Inc Corporate Summary
    Table 97. 3SBio Inc Antibody and Recombinant Protein CDMO Product Offerings
    Table 98. 3SBio Inc Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
    Table 99. Porton Corporate Summary
    Table 100. Porton Antibody and Recombinant Protein CDMO Product Offerings
    Table 101. Porton Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Antibody and Recombinant Protein CDMO Segment by Type in 2021
    Figure 2. Antibody and Recombinant Protein CDMO Segment by Application in 2021
    Figure 3. Global Antibody and Recombinant Protein CDMO Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Antibody and Recombinant Protein CDMO Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Antibody and Recombinant Protein CDMO Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Antibody and Recombinant Protein CDMO Revenue in 2021
    Figure 8. By Type - Global Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
    Figure 12. US Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
    Figure 16. Germany Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 17. France Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
    Figure 24. China Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 28. India Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
    Figure 30. Brazil Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
    Figure 33. Turkey Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
    Figure 37. Batavia Biosciences Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Grifols Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. HALIX Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Biovian Oy Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Catalent Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Goodwin Biotechnology Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Merck Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Wuxibiologics Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Bioinnobio Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Eurogentec Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. HJB Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. Bibo Pharma Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. MabPlex International Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. Genscriptprobio Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 55. Vetter Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 56. Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 57. Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 58. Lonza Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 59. 3SBio Inc Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 60. Porton Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)